Research Interest: Epidemiology, pathogenesis, diagnosis and treatment of fatty liver (metabolic and viral); genetic determinants of fatty liver; metabolic syndrome; insulin resistance; association between fatty liver, metabolic syndrome, diabetes and cardiovascular diseases;  liver ultrasonography.

Research Interest: Area of Gastrointestinal Cancer and Inflammatory Bowel Disease. 

Research Interest: Diabetes; Metabolic Syndrome; Osteoporosis

Research Interest: Deep Specialization in Research Involve; Obesity and Associated Disorder, Its Mechanism and Treatment. Metabolic Syndrome-Food Additives and Its Effect on the Bodyorgans. Also the Biochemical, Oxidative Stress and Advanced Biomarkers in Health and Diseases. Recently Involved in Nanomedical Materials as Antioxidant for Health Maintainance.

Research Interest: He has Vast Experience in Characterization of New Chemical Entities (NCE’S) for Early Stage Dosage form Development, Preparation of Nano Particles, Spray Dried Powders, Solubility Screening, Bio-Availability Enhancement, Granulation and Fluid Bed Drying, Compression Using Rotary Tablet Press, Coating, Stability Studies and Tech Transfer Etc.

Research Interest: He Also Conducted Basic Research in Regard to the Investigation of the Role of Immunological Aspects in Kidney Diseases Including Nephritic Syndrome and Diabetic Nephropathy.

Dr. Mehta’s research program focuses on the role of innate immunity and inflammation in the development of cardiovascular and metabolic diseases. Using a trans-disciplinary approach that involves genetic epidemiology, translational medicine, and novel cardiovascular imaging approaches, Dr. Mehta and his team study how inflammation affects insulin resistance, the development of metabolic syndrome, and lipoprotein dysfunction, all of which are risk factors for atherosclerosis and subsequent cardiovascular disease (CVD).

Research Interest: My Research has Focused on Understanding the BBB, Changes that Occur in the Blood-Tumor-Barrier (BTB), and Drug Uptake Therein. To this End, I Have Worked and Gained Significant Amount of Knowledge on Factors Influencing Anticancer Delivery and Activity in Brain aBrain Metastases Developed from Breast Cancer in Mouse Models. These Include: (1) How BBB is Altered in Mouse Models of Brain Metastases of Breast Cancer. (2) Pharmacokinetic-Pharmacodynamic Relationship of Anticancer Drugs in Brain Metastases. (3) in Vitro- In Vivo Correlations (IVIVC) to Predict Optimum Therapeutic Concentrations for Treatment of Brain Metastases. (4) Improving Targeted Anticancer Drug Delivery to Brain Tumors by Inhibiting Efflux Transporters and Piggy Backing Drugs to Substrates of Influx Transporters at the BBB.

Lawrence Lavery is a Professor in the Department of Plastic Surgery, as well as Director of Clinical Research in the Department of Plastic Surgery, at the University of Texas Southwestern Medical Center, Dallas, TX.  His research group has published 210 peer reviewed papers and has received extramural funding from the Veterans Administration, the National Institute of Health, the Agency for Healthcare Research and Quality, the American Diabetes Association, and the American College of Foot and Ankle Surgeons. 

Research Interest: Diabetes, Ulcers, Infections, Neuropathy and Osteomyelities

Grants: Supporting with number of grants

List of Publications:
1.    Lavery LA, Oz OK, Bhavan K, Wukich DK.  Diabetic Foot Syndrom in the Twenty-First Century.  Clin Podiatr Med Surg. 2019 July; 3, 355-359.
2.    Kim, PJ, Attinger CE, Orgill D, Galiano RD, Steinberg JS, Evans KK, Lavery LA.  Complex Lower Extremity Wound in the Complex Host:  Results from a Multicenter Registry.  Plastic and Reconstructive Surgery-Global. 2019 Apr.  Epub ahead of print.
3.    Ahn J, Raspovic KM, Liu GT, Lavery LA, La Fontaine J, Nakonezny PA, Wukich, DK.  Lower Extremity Necrotizing Fasciitis in Diabetic and Nondiabetic Patients:  Mortality and Amputation.  Int J Low Extrem Wounds.  2019 Apr.  Epub ahead of print.  PMID: 30929530.
4.    Lavery LA, Bhavan K, Wukich DK.  Biofilm and diabetic foot ulcer healing:  all hat and no cattle.  Annals of Translational Medicine 2019 Mar.  Epub ahead of print.
5.    La Fontaine J, Crisologo PA, Lavery L.  Current concepts in curative surgery for diabetic forefoot ulcers.  The Foot 2019 Jan 10 (39) 37-44.  Epub ahead of print.
6.    Olson E, Mahar KM, Morgan L, Fillmore C, Holland C, Lavery L.  Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and Patients with Diabetic Foot Ulcers.  Clin Pharmacol Drug Dev. 2019 Feb 5. Epub ahead of print.  PMID:  30720931.
7.    Liu JW, Ahn J, Raspovic KM, Liu GT, Nakonezny PA, Lavery LA, Wukich DK.  Increased Rates of Readmission, Reoperation, and Mortality Following Open Reduction and Internal Fixation of Ankle Fractures are Associated with Diabetes Mellitus. J Foot Ankle Surg. 2019 Feb 11. Epub ahead of print.
8.    Ryan EC, Ahn J, Wukich DK, Kim PJ, La Fontaine J, Lavery LA.  Diagnostic Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein in Osteomyelitis of the Foot in Persons without Diabetes.  J Foot Ankle Surg. 2019 Jan 23.  Epub ahead of print.
9.    Ahn J, Raspovic KM, Liu GT, Lavery LA, La Fontaine J, Nakonezny PA, Wukich DK.  Rental Function as a Predictor of Early Transmetatarsal Amputation Failure.  Foot Ankle Spec. 2018 Dec 12.  Epub ahead of print.  PMID:  30537872.
10.    Lavery LA, Crisologo PA.  Non-invasive vascular screening test to diagnose peripheral vascular disease.  Ann Transl Med. 2018 Dec; 6(Suppl 2).  PMID:  30740429.
11.    Yavuz M, Ersen A, Hartos J, LAVERY LA, Wukich D, Hirschman G, Armstrong D, Quiben M, Adams L.  Temperature as a Causative factor in Diabetic Foot Ulceration:  A Call to Revisit Ulcer Pathomechanics.  J Am Podiatr Med Assoc. 2018 Nov 14. (Epub ahead of print).  PMID:  30427732.
12.    Niederauer MQ, Michalek JE, Liu Q, Papas KK, LAVERY LA, Armstrong DG.  Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control:  a randomized, double-blind, multicenter study.  J Wound Care.  2018 Sep 1;27(Sup9): S30-S45. PMID: 30207844.
13.    LAVERY, LA, Fulmer J, Shebetka KAS, Regulski M, Vayer, D, Fried D, Kashefsky H, Owings TM, Nadarajah J, Phelan DHK.  Open-label Extension Phase of a Chronic Diabetic Foot Ulcer Multicenter, Controlled, Ramdomised Clinical Trial Using Cryopreserved Placental Membrance.  Wounds Epub 2018 June.  PMID:  30256747.
14.    Raspovic KM, Wukich DK, Naiman DQ, LAVERY LA, Kirsner RS, Kim PJ, Steinberg JS, Attinger CE, Danilkovitch A.  Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting.  Wound Repair Regen, 2018 Mar; 26(2): 213-220.  PMID:  29683538.
15.    Ahn J, Del Core MA, Wukich DK, Liu GT, Lalli T, VanPelt MD, La Fontaine J, Lavery LA, Raspovic KM.  Scoring mental health quality of life with the SF-36 in patients with and without diabetes foot complications.  Int J Low Extrem Wounds.  2018 Mar.  PMID:  29546783.
16.    LAVERY LA, Lavery DC, Hunt NA, La Fontaine J, Lavery RD.  Does the start of dialysis initiate a period of increased risk of ulceration or amputation?  J Am Podiatr Med Assoc.  2018 Jan; 108-(1):1-5.  PMID:  29547031.
17.    Van Asten SAV, Mithani M, Peters EIG, La Fontaine J, Kim PJ, Lavery LA.  Complications during the treatment of diabetic foot osteomyelitis.  Diabetes Res Clin Pract. 2018 Jan;135:58-64. PMID: 28951333. 
18.    Crisologo PA, Lavery LA.  Remote home monitoring to identify and prevent diabetic foot ulceration.  Ann Transi Med.  2017 Nov;5(21):430.  PMID:  29201882.
19.    Lavery LA, Ryan EC.  Does Continuous Diffusion of Oxygen Improve Diabetic Foot Ulcer Healing?  J Diabetes Sci Technol. 2017 Sep; 11(5):892-893.  PMID: 28728437.
20.    Sanniec K, Nguyen T, van Asten S, La Fontaine J, Lavery LA.  Split-Thickness Skin Grafts to the Foot and Ankle of Diabetic Patients.  J Am Podiatr Med Assoc.  2017 Sep; 107(5):365-368.  PMID:  29077498.

Research Interest: Obesity, Chronic Hronic Inflammation, Inflammatory Disease, Cancer

Research Interest: Obesity, Mind and Inhibitory Control, Metabolic Syndrome, Rationale, Cardiovascular Disease 

Research Interest: Nutrition, Weight management, Obesity Evaluation, Behavior Change Interventions, Critical Thinking, Health Disparity, Curriculum and Program Development, Type 2 Diabetes

Research Interest: Integrated Pharmaco-Physiology, Brain-Gut Interactions, Stress-Related Functional Gastrointestinal Diseases, Ingestive Behavior-Associated Gastrointestinal Neuroendocrinology, and Bariatric Surgery

Research Interest: Molecular Pharmacology, Chinese Medicines and Diabetes Mellitus, Effects and Mechanism of Natural Products on Cardio-Cerebrovascular Disease.

Research Interest: Dietetics Applied to Bariatric Ssurgery; Clinical Impact of Bariatric Surgery on Patient’s Body Composition (Fat Mass and Fat-Free Mass) and Resting Metabolic Rate; Pre- and Post-Operative Treatment of Micronutrient Deficiencies in Patients that Underwent Bariatric Surgery.